77.4 F
New York
Thursday, July 29, 2021

Axovant [NASDAQ: AXGT] Inks AXO-LENTI-PD Supply Deal With Oxford Biomedica

Must read

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Axovant Gene Therapies Ltd. [NASDAQ: AXGT] disclosed today that its subsidiary has inked a three-year Clinical Supply Agreement (CSA) with Oxford Biomedica Plc [LSE: OXB].

The CSA between the two firms in June 2018 for a worldwide licensing agreement for the Parkinson’s disease gene therapy program OXB-102, now called AXO-Lenti-PD. AXO-Lenti-PD is an investigational gene therapy developed for the treatment of Parkinson’s disease.

As per the deal, to continue the ongoing and future clinical development of AXO-Lenti-PD Oxford Biomedica will make GMP batches for AXGT. Axovant Gene Therapies is currently directing the SUNRISE-PD phase 2 Trial with AXO-Lenti-PD.

Shares of Axovant had traded up 0.34% and up +0.01 during the trading of Thursday. It has a day low range of $2.93 and a day high range of $3.03. If we look at its liquidity, the quick ratio for Axovant Gene Therapies is 2.70. Similarly, its current ratio is the same as the quick ratio.

Continuing to look at its profitability, its return on assets (ROA) is -92.70% and return on equity (ROE) is -257.10%. Axovant has reported the income of -72.60 million. It has total market capitlization of 125.79 million.

During the period of 52-week, this company’s stocks have fluctuated between the low of $1.41 and a high of $8.08. It has increased 112.06% from its 52-weeks low and moved down -63.00% from its 52-weeks high. Axovant is looking forward to work with Oxford Biomedica for the development of AXO-Lenti-PD.

More articles

Latest article

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...

Digital Realty [NYSE: DLR] and Brookfield Announces Joint Venture

Digital Realty Trust, Inc.   and Brookfield Infrastructure Partners L.P. and its institutional partners disclosed on Wednesday that they have launched a 50/50 joint...

Red Cat [NASDAQ: RCAT] Announces Acquisition of Teal Drones

Red Cat Holdings, Inc. has inked an agreement on Tuesday to buy Teal Drones in an all-stock transaction. This acquisition will add Teal...